These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia. Wilcox WR; Tavormina PL; Krakow D; Kitoh H; Lachman RS; Wasmuth JJ; Thompson LM; Rimoin DL Am J Med Genet; 1998 Jul; 78(3):274-81. PubMed ID: 9677066 [TBL] [Abstract][Full Text] [Related]
3. Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism. Bonaventure J; Rousseau F; Legeai-Mallet L; Le Merrer M; Munnich A; Maroteaux P Am J Med Genet; 1996 May; 63(1):148-54. PubMed ID: 8723101 [TBL] [Abstract][Full Text] [Related]
4. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Naski MC; Wang Q; Xu J; Ornitz DM Nat Genet; 1996 Jun; 13(2):233-7. PubMed ID: 8640234 [TBL] [Abstract][Full Text] [Related]
5. Mutations in the fibroblast growth factor receptor 3 (FGFR3) cause achondroplasia, hypochondroplasia, and thanatophoric dysplasia: Taiwanese data. Tsai FJ; Tsai CH; Chang JG; Wu JY Am J Med Genet; 1999 Sep; 86(3):300-1. PubMed ID: 10482885 [No Abstract] [Full Text] [Related]
6. Long-term survival in typical thanatophoric dysplasia type 1. Baker KM; Olson DS; Harding CO; Pauli RM Am J Med Genet; 1997 Jun; 70(4):427-36. PubMed ID: 9182787 [TBL] [Abstract][Full Text] [Related]
7. G370C mutation in the FGFR3 gene in a Japanese patient with thanatophoric dysplasia. Katsumata N; Kuno T; Miyazaki S; Mikami S; Nagashima-Miyokawa A; Nimura A; Horikawa R; Tanaka T Endocr J; 1998 Apr; 45 Suppl():S171-4. PubMed ID: 9790257 [TBL] [Abstract][Full Text] [Related]
8. [From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor]. van Ravenswaaij-Arts CM; Losekoot M Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1056-9. PubMed ID: 11414167 [TBL] [Abstract][Full Text] [Related]
9. An unusual radiological finding in thanatophoric dysplasia type 1 with common mutation of the fibroblast growth factor receptor-3 (FGFR3) gene (Arg248Cys). Camera G; Baldi M; Baffico M; Pozzolo S Am J Med Genet; 1997 Jul; 71(1):122-3. PubMed ID: 9215781 [No Abstract] [Full Text] [Related]
10. Common mutations in the gene encoding fibroblast growth factor receptor 3 account for achondroplasia, hypochondroplasia and thanatophoric dysplasia. Bonaventure J; Rousseau F; Legeai-Mallet L; Le Merrer M; Munnich A; Maroteaux P Acta Paediatr Suppl; 1996 Oct; 417():33-8. PubMed ID: 9055906 [TBL] [Abstract][Full Text] [Related]
11. Thanatophoric dysplasia type I. Chang TK; Wang Y; Liu AM; Tung JC Acta Paediatr Taiwan; 2001; 42(1):39-41. PubMed ID: 11270184 [TBL] [Abstract][Full Text] [Related]
12. Occurrence of thanatophoric dysplasia type I (R248C) and hypochondroplasia (N540K) mutations in two patients with achondroplasia phenotype. Camera G; Baldi M; Strisciuglio G; Concolino D; Mastroiacovo P; Baffico M Am J Med Genet; 2001 Dec; 104(4):277-81. PubMed ID: 11754059 [TBL] [Abstract][Full Text] [Related]
13. Thanatophoric dysplasia type I with syndactyly. Brodie SG; Kitoh H; Lipson M; Sifry-Platt M; Wilcox WR Am J Med Genet; 1998 Nov; 80(3):260-2. PubMed ID: 9843049 [TBL] [Abstract][Full Text] [Related]
14. Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I. Tavormina PL; Rimoin DL; Cohn DH; Zhu YZ; Shiang R; Wasmuth JJ Hum Mol Genet; 1995 Nov; 4(11):2175-7. PubMed ID: 8589699 [No Abstract] [Full Text] [Related]
15. A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene. Tavormina PL; Bellus GA; Webster MK; Bamshad MJ; Fraley AE; McIntosh I; Szabo J; Jiang W; Jabs EW; Wilcox WR; Wasmuth JJ; Donoghue DJ; Thompson LM; Francomano CA Am J Hum Genet; 1999 Mar; 64(3):722-31. PubMed ID: 10053006 [TBL] [Abstract][Full Text] [Related]
16. Radiological and histological variants of thanatophoric dysplasia are associated with common mutations in FGFR-3. Nerlich AG; Freisinger P; Bonaventure J Am J Med Genet; 1996 May; 63(1):155-60. PubMed ID: 8723102 [TBL] [Abstract][Full Text] [Related]
17. Prenatal diagnosis and genetic analysis of type I and type II thanatophoric dysplasia. Chen CP; Chern SR; Shih JC; Wang W; Yeh LF; Chang TY; Tzen CY Prenat Diagn; 2001 Feb; 21(2):89-95. PubMed ID: 11241532 [TBL] [Abstract][Full Text] [Related]
18. Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization. Adar R; Monsonego-Ornan E; David P; Yayon A J Bone Miner Res; 2002 May; 17(5):860-8. PubMed ID: 12009017 [TBL] [Abstract][Full Text] [Related]
19. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Bellus GA; McIntosh I; Smith EA; Aylsworth AS; Kaitila I; Horton WA; Greenhaw GA; Hecht JT; Francomano CA Nat Genet; 1995 Jul; 10(3):357-9. PubMed ID: 7670477 [TBL] [Abstract][Full Text] [Related]
20. Mutations causing achondroplasia and thanatophoric dysplasia alter bFGF-induced calcium signals in human diploid fibroblasts. Nguyen HB; Estacion M; Gargus JJ Hum Mol Genet; 1997 May; 6(5):681-8. PubMed ID: 9158142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]